Characterizing the Contribution of the Group B Streptococcal Surface Adhesin BspC Interaction with Host Vimentin to Disease and Colonization

表征 B 族链球菌表面粘附素 BspC 与宿主波形蛋白相互作用对疾病和定植的贡献

基本信息

  • 批准号:
    10312484
  • 负责人:
  • 金额:
    $ 3.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Group B Streptococcus (GBS, also known as Streptococcus agalactiae) is a Gram-positive, -hemolytic bacterium normally found in the human gastrointestinal and urogenital tracts. GBS remains a leading cause of invasive disease in newborns and certain adult populations including pregnant women. The development of GBS disease is initiated by the asymptomatic colonization of the female genital tract and during pregnancy can be associated with chorioamnionitis, puerperal endometritis and preterm labor. Approximately 20-30% of healthy women are colonized rectovaginally with GBS; the majority of infants born to these women will themselves become colonized with the bacterium. Newborn infection also results from ascending infection of the bacterium through the placental membranes to initiate infection in utero. GBS is the principle etiologic agent of neonatal bacterial meningitis, and GBS meningeal infection results in 10-15% mortality despite antibiotic treatment. Additionally, up to 40% of survivors develop permanent neurological sequelae, including cognitive defects, seizure activity, and cerebral ischemia. To access the central nervous system (CNS) and cause meningitis blood-borne GBS must penetrate the blood-brain barrier (BBB); however, little is known about the very first and crucial interaction between GBS and the BBB that initiates bacterial crossing and disease progression. This proposal seeks to characterize the role of a newly identified GBS Antigen I/II family adhesin, BspC, to the pathogenesis of colonization and CNS disease. We have recently determined that BspC promotes attachment to BBB endothelium and contributes to the development of GBS meningitis. Further we have discovered that BspC interacts directly with vimentin, a widely distributed intermediate filament protein found in blood vessel endothelial cells. Thisproposal seeks toidentify the region on BspC that interacts with vimentin, and to characterize the role of this interaction in GBS meningitis and colonization of the female reproductive tract. I hypothesize that the binding region is contained within the globular variable domain (V- domain) of BspC and contributes to both GBS meningitis and vaginal colonization/ascending infection. These hypotheses will be addressed with both in vitro and in vivo models of BBB penetration and vaginal colonization in the following specific aims: Aim 1: Identify the critical regions and amino acids required for BspC V-domain- vimentin interaction; Aim 2: Characterize the role of BspC and vimentin in the female reproductive tract. These data will clarify the crucial role of Antigen I/II proteins to GBS colonization and disease and provide fundamental mechanistic insights that may inform new treatment strategies to prevent colonization and ultimately bacterial meningitis.
项目摘要 B族链球菌(GBS,也称为无乳链球菌)是革兰氏阳性、溶血性链球菌, 通常在人类胃肠道和泌尿生殖道中发现的细菌。GBS仍然是导致 新生儿和某些成年人群(包括孕妇)的侵袭性疾病。的发展 GBS疾病是由女性生殖道的无症状定植引起的,在怀孕期间, 与绒毛膜炎、产褥期子宫内膜炎和早产有关。约20-30% 健康妇女的直肠阴道定植有GBS;这些妇女所生的大多数婴儿将 它们自身也被细菌定殖。新生儿感染也是由 细菌通过胎盘膜在子宫内引发感染。GBS是主要病因 新生儿细菌性脑膜炎的病原体,GBS脑膜感染导致10-15%的死亡率, 抗生素治疗此外,高达40%的幸存者发展为永久性神经系统后遗症,包括 认知缺陷癫痫发作和脑缺血进入中枢神经系统(CNS), 引起脑膜炎的血源性GBS必须穿透血脑屏障(BBB);然而,对血脑屏障的作用知之甚少。 GBS和BBB之间的第一个和关键的相互作用,引发细菌交叉和疾病 进展该提议试图描述新鉴定的GBS抗原I/II家族粘附素的作用, BspC与定植和CNS疾病的发病机制有关。我们最近确定BspC 促进对BBB内皮的附着并有助于GBS脑膜炎的发展。我们越 我发现BspC直接与波形蛋白相互作用,波形蛋白是一种广泛分布的中间丝蛋白 发现于血管内皮细胞。该提案旨在确定BspC上与以下方面相互作用的区域: 波形蛋白,并描述这种相互作用在GBS脑膜炎和女性定植中的作用。 生殖道我假设结合区包含在球状可变结构域(V-)内。 结构域),并有助于GBS脑膜炎和阴道定植/上行感染。这些 假设将通过血脑屏障渗透和阴道定植的体外和体内模型来解决 目的1:鉴定BspC V-结构域所需的关键区域和氨基酸, 波形蛋白相互作用;目的2:表征BspC和波形蛋白在女性生殖道中的作用。这些 这些数据将阐明抗原I/II蛋白对GBS定植和疾病的关键作用, 基本的机制见解,可以为新的治疗策略提供信息,以防止殖民化, 最终导致细菌性脑膜炎。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Haider Syed Manzer其他文献

Haider Syed Manzer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 3.4万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10419967
  • 财政年份:
    2022
  • 资助金额:
    $ 3.4万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10592441
  • 财政年份:
    2022
  • 资助金额:
    $ 3.4万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10369750
  • 财政年份:
    2021
  • 资助金额:
    $ 3.4万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10633248
  • 财政年份:
    2021
  • 资助金额:
    $ 3.4万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10487516
  • 财政年份:
    2021
  • 资助金额:
    $ 3.4万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    10228564
  • 财政年份:
    2018
  • 资助金额:
    $ 3.4万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    9347041
  • 财政年份:
    2017
  • 资助金额:
    $ 3.4万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9480702
  • 财政年份:
    2016
  • 资助金额:
    $ 3.4万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9906853
  • 财政年份:
    2016
  • 资助金额:
    $ 3.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了